| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-05 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.21 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0008 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.19 | 0.3 |